Beta Bionics (BBNX) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Meeting opened by the President and CEO, with introductions of board members and proxies for the meeting.
Independent auditors and the Corporate Secretary/CFO were introduced, with roles clarified for the meeting.
Overview of voting outcomes
Quorum confirmed, allowing business to proceed and polls to open for voting.
Two proposals presented: election of two Class 1 directors and ratification of the audit firm.
Voting conducted electronically, with opportunity for stockholders to change votes before polls closed.
Preliminary results: both director nominees elected and audit firm ratified; final results to be filed in Form 8-K.
Q&A with stakeholders
Opportunity provided for stockholders to submit questions related to proposals or auditors; no questions were submitted.
Latest events from Beta Bionics
- Automated insulin delivery, rapid innovation, and bihormonal tech drive growth and differentiation.BBNX
Morgan Stanley 23rd Annual Global Healthcare Conference8 Jul 2026 - Net sales rose 443% to $65.1M in 2024; 2025 revenue guided at $80–$85M with pharmacy growth.BBNX
Q4 20248 Jul 2026 - Pharmacy channel guidance raised, Mint patch pump unveiled, and iLet shows strong adaptive outcomes.BBNX
Status Update8 Jul 2026 - Strong Q1, pharmacy channel growth, and Mint patch pump launch targeted for end of 2027.BBNX
Bank of America Global Healthcare Conference 202619 May 2026 - Automation, pharmacy access, and pipeline innovation drive growth and future market leadership.BBNX
TD Cowen 46th Annual Health Care Conference29 Apr 2026 - Q1 2026 net sales up 57% to $27.6M, gross margin 59.5%, net loss narrowed to $21.9M.BBNX
Q1 202623 Apr 2026 - 2025 net sales rose 54% to $100.3M, with Q4 margin at 59% and robust pharmacy channel growth.BBNX
Q4 202511 Apr 2026 - Vote on director elections and auditor ratification at the virtual annual meeting on May 21, 2026.BBNX
Proxy filing10 Apr 2026 - Virtual meeting to elect directors, ratify auditor, and review governance, compensation, and ESG.BBNX
Proxy filing10 Apr 2026